American Century Companies’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
NCGI
American Century Companies's OPRX Position: Q4 2025 in Review
American Century Companies sold out of OptimizeRx (OPRX) in Q4 2025, closing a stake of 24,164 shares — an estimated $495K sold.
American Century Companies first reported a position in OPRX in Q3 2021 and held it in 12 quarters. The position peaked at $32.7M in Q3 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2025.
- American Century Companies reported no remaining OptimizeRx position as of Q4 2025 after selling out during the quarter.
- American Century Companies sold 24,164 OptimizeRx shares in Q4 2025, an estimated $495K.
- American Century Companies first reported a position in OptimizeRx in Q3 2021 and held it in 12 quarters.
- American Century Companies's OptimizeRx position peaked at $32.7M in Q3 2021.
- 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2025.
Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.